31 research outputs found
Association of Hypertension with Long-Term Overweight Status and Weight Gain: the CroHort Study
Overweight is associated with hypertension, but longitudinal studies on the effect of weight gain on blood pressure are relatively rare. Aim of this study was to investigate association of long-term overweight status as well as of becoming overweight with hypertension. Odds of hypertension in 2008 were calculated for 1,383 respondents from Croatian Adult Health Cohort Study (CroHort) who had normal blood pressure in 2003. The results showed that for women both long-term overweight status and recently becoming overweight (in the last 5 years) were significantly associated with development of hypertension, while for men this was true only for long-term overweight. Prevention activities aimed at
maintenance of normal body weight should be important part of primary prevention of hypertension
Informacijski sustav za nadzor nad zaraznim bolestima
Razvoj informacijskog sustava za praÄenje i nadzor nad zaraznim bolestima ima za cilj primjeniti suvremene informacijsko-komunikacijske tehnologije u nadzoru nad zaraznim bolestima. U tijeku je razvoj elektronske prijave zaraznih bolesti i elektronske prijave epidemije koji Äine prvu fazu sustava, dok Äe u drugoj fazi, na jedinstvenoj platformi, biti omoguÄeno pojaÄano praÄenje pojedinih bolesti kao Å”to su TBC, HIV, legioneloze, akutne mlohave kljenuti, Creutzfeldt Jakobove bolesti, meningitis/sepsa, morbili, parotitis i rubela, malarija, zbirno izvjeÅ”Äe o gripi i virusni hepatitisi. U kasnijim fazama radit Äe se na povezivanju sa sustavom e-mikrobioloÅ”ki laboratorij i e-nalaz.Centralni sustav elektronske prijave zaraznih bolesti poveÄat Äe kvalitetu i uÄinkovitost komunikacije uz osiguranje najviÅ”ih standarda zaÅ”tite podataka. Sustav omoguÄava prihvat prijave zaraznih bolesti iz svih postojeÄih izvora informacija na primarnoj, sekundarnoj i tercijarnoj razini zdravstvene zaÅ”tite. Za sve prijavitelje nudi se web suÄelje za prijavu zaraznih bolesti, a onima koji imaju informatiÄka rjeÅ”enja omoguÄena je razmjena elektroniÄkih paketa informacija prema propisanom standardu. Na zaprimljenim informacijama aktivnosti provode sve tri razine epidemioloÅ”ke djelatnosti i to higijensko-epidemioloÅ”ke ispostave (prema mjestu prebivaliÅ”ta oboljelog), te službe za epidemiologiju na županijskoj i nacionalnoj razini. Prijave prolaze svoj ciklus obrade i nakon njihovog potvrÄivanja evidentiraju se u Registru zaraznih bolesti pri HZJZ.Forma elektroniÄke prijave usklaÄena je s nacionalnim zakonskim okvirom i meÄunarodnim smjernicama i definicijama ECDC-a. U tijeku su aktivnosti na usklaÄivanju postojeÄe e-prijave koja veÄ viÅ”e godina postoji u primarnoj zdravstvenoj zaÅ”titi. Jedinstvena forma vrijedit Äe i za bolniÄke sustave (BIS). U tom smislu u tijeku su dogovori s predstavnicima CEZIH-a i Klinike za infektivne bolesti ādr Fran MihaljeviÄā.Novi sustav omoguÄit Äe prijavljivanje zarazne bolesti u realnom vremenu i pravovremene intervencije epidemiologa, kvalitetan nadzor i uvid u kretanje zaraznih bolesti.Sustav Äe omoguÄiti izvjeÅ”tavanje (na nacionalnoj razini i prema meÄunarodnim institucijama) prema svim prikupljanim parametrima.
Increased Odds of Metabolic Dysfunction-Associated Steatotic Liver Disease Are Linked to Reduced n-6, but Not n-3 Polyunsaturated Fatty Acids in Plasma
The increasing prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) underscores the need for better understanding of its complex pathogenesis. Lipid accumulation in hepatocytes is among principal mechanisms contributing to MASLD development. While routine lipid parameters are well studied, the profile of circulating fatty acids in MASLD patients remains less explored. This study aimed to assess relative proportions of individual fatty acids in plasma of MASLD patients and to explore their associations with other biochemical markers of MASLD. Ninety-one patients and 48 healthy individuals were enrolled. The relative proportions of fatty acids in plasma were determined using gas chromatography with FID detection. Proportions of total n-6 polyunsaturated fatty acids (PUFAs) and linoleic acid (LA) in plasma were lower in MASLD patients (p = 0.001 and p = 0.004, respectively), with no differences observed in n-3 PUFAs. Total plasma n-6 PUFAs correlated negatively with body mass index, hepatic steatosis indices, triglyceride concentration and coronary risk index. Decreased prevalence of n-6 PUFAs in plasma was independently associated with higher odds of MASLD (OR = 0.769; CI: 0.611ā0.968; p = 0.025). Our findings indicate an altered circulatory fatty acid distribution in MASLD, characterized by a reduced amount of n-6 PUFAs, particularly LA, which may have significant implications for the prevention and treatment of MASLD
LncRNAs as Regulators of Atherosclerotic Plaque Stability
Current clinical data show that, despite constant efforts to develop novel therapies and clinical approaches, atherosclerotic cardiovascular diseases (ASCVD) are still one of the leading causes of death worldwide. Advanced and unstable atherosclerotic plaques most often trigger acute coronary events that can lead to fatal outcomes. However, despite the fact that different plaque phenotypes may require different treatments, current approaches to prognosis, diagnosis, and classification of acute coronary syndrome do not consider the diversity of plaque phenotypes. Long non-coding RNAs (lncRNAs) represent an important class of molecules that are implicated in epigenetic control of numerous cellular processes. Here we review the latest knowledge about lncRNAsā influence on plaque development and stability through regulation of immune response, lipid metabolism, extracellular matrix remodelling, endothelial cell function, and vascular smooth muscle function, with special emphasis on pro-atherogenic and anti-atherogenic lncRNA functions. In addition, we present current challenges in the research of lncRNAsā role in atherosclerosis and translation of the findings from animal models to humans. Finally, we present the directions for future lncRNA-oriented research, which may ultimately result in patient-oriented therapeutic strategies for ASCVD
Markeri redoks statusa kod pacijenata sa nealkoholnom masnom boleÅ”Äu jetre
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease,
present in up to 30% of the adult population worldwide (1). Triglycerides accumulation in
hepatocytes (steatosis) represents the root cause of NAFLD and is associated with oxidative
stress, which could further lead to fibrosis and cell death of hepatocytes (2). The aim of this
research was to identify redox status markers for predicting the risk of developing steatosis.
158 participants were included. Steatosis was confirmed by ultrasound in 101 subjects,
while the remaining 57 were in the control group. The following markers of redox status
were determined in serum and plasma samples of all subjects: superoxide dismutase 1
(SOD1), paraoxonase (PON1), malondialdehyde (MDA) and superoxide anion (O2.-). For this
purpose, spectrophotometric methods and enzyme immunosorbent assays were used. SOD1
was statistically significantly higher (P<0.001), while O2 .- was significantly lower in the
patient group (P<0.001). SOD1 was significantly negatively correlated with O2.- (Ļ= -0.494,
P<0.001) and MDA (Ļ= -0.242, P=0.002). Univariate binary logistic regression analysis
showed a positive association between SOD1 and the presence of steatosis (OR=1.018, 95%
CI 1.005-1.031; P=0.005), as well as a negative association between O2 .- and the presence of
steatosis (OR=0.959, 95% CI 0.941-0.978; P<0.001). Multivariate analysis singled out SOD1
(OR=1.024, 95% CI 1.006-1.041; P=0.007) and O2.- (OR=0.965, 95% CI 0.942-0.989;
P=0.004) as independent predictors for the presence of steatosis in our subjects. The redox
status parameters, SOD1 and O2, respectively, showed a positive and negative prediction of
the presence of statosis in our subjects.Nealkoholna masna bolest jetre (eng. nonalcoholic fatty liver disease, NAFLD) je
najÄeÅ”Äe hroniÄno oboljenje jetre, prisutno i u do 30% adultne populacije Å”irom sveta (1).
ZnaÄajnu ulogu u nastanku NAFLD ima akumulacija triglicerida u hepatocitima ā steatoza,
koja je povezana sa oksidativnim stresom, a koji dalje vodi fibrozi i Äelijskoj smrti hepatocita
(2). Cilj ovog istraživanja bio je identifikacija markera redoks statusa za predviÄanje rizika za
nastanak steatoze. Studija je obuhvatila 158 ispitanika iz KliniÄko bolniÄkog centra Zemun.
Steatoza je potvrÄena ultrazvukom kod 101 ispitanika, dok je preostalih 57 Äinilo kontrolnu
grupu. U uzorcima seruma i plazme svih ispitanika odreÄeni su sledeÄi markeri redoks
statusa: superoksid dismutaza 1 (SOD1), paraoksonaza (PON1), malondialdehid (MDA) i
superoksidni anjon (O2.-). U tu svrhu koriÅ”Äene su spektrofotometrijske metode i enzimski
imunosorbentni testovi. SOD1 je bila statistiÄki znaÄajno viÅ”a (P<0,001), dok O 2.- znaÄajno
niži u grupi pacijenata (P<0,001), dok se PON1 i MDA nisu znaÄajno razlikovali izmeÄu
grupa. SOD1 je bila u znaÄajnoj negativnoj korelaciji sa O 2.- (Ļ=-0,494, P<0,001) i MDA (Ļ= -
0,242, P=0,002). Univarijatna binarna logistiÄka regresiona analiza je pokazala pozitivnu
asocijaciju izmeÄu SOD1 i prisustva steatoze (OR=1,018, 95% CI 1,005-1,031; P=0,005), kao i
negativnu asocijaciju izmeÄu O 2.- i prisustva steatoze (OR=0,959, 95% CI 0,941-0,978;
P<0,001). Multivarijantna analiza je izdvojila SOD1 (OR=1,024, 95% CI 1,006-1,041;
P=0,007) i O2.- (OR=0,965, 95% CI 0,942-0,989; P=0,004) kao nezavisne prediktore za
prisustvo steatoze kod naŔih ispitanika. Parametri redoks statusa, SOD1 i O 2.- redom, su
pokazali pozitivnu, odnosno negativnu predikciju prisustva statoze kod naÅ”ih ispitanika.VIII Kongres farmaceuta Srbije sa meÄunarodnim uÄeÅ”Äem, 12-15.10.2022. Beogra
Health-related quality of life in elderly patients hospitalized with chronic heart failure
Background: Chronic heart failure is a very common condition in the elderly, characterized not only by high mortality rates, but also by a strong impact on health-related quality of life (HRQOL). Previous studies of HRQOL in elderly heart failure subjects have included mostly outpatients, and little is known about determinants of HRQOL in hospitalized elderly population, especially in Serbia. In this study, we tried to identify factors that influence HRQOL in elderly patients hospitalized with chronic heart failure in Serbia. Methods: The study population consisted of 136 patients aged 65 years or older hospitalized for chronic heart failure. HRQOL was assessed using the Minnesota Living with Heart Failure questionnaire. Predictors of HRQOL were identified by multiple linear regression analysis. Results: Univariate analysis showed that patients with lower income, a longer history of chronic heart failure, and longer length of hospital stay, as well as those receiving aldosterone antagonists and digoxin, taking multiple medications, in a higher NYHA class, and showing signs of depression and cognitive impairment had significantly worse HRQOL. Presence of depressive symptoms (P lt 0.001), higher NYHA class (P=0.021), lower income (P=0.029), and longer duration of heart failure (P=0.049) were independent predictors of poor HRQOL. Conclusion: Depressive symptoms, higher NYHA class, lower income, and longer duration of chronic heart failure are independent predictors of poor HRQOL in elderly patients hospitalized with chronic heart failure in Serbia. Further, there is an association between multiple medication usage and poor HRQOL, as well as a negative impact of cognitive impairment on HRQOL. Hence, measures should be implemented to identify such patients, especially those with depressive symptoms, and appropriate interventions undertaken in order to improve their HRQOL
MeÄunarodna suradnja na podruÄju nadzora i kontrole zaraznih bolesti
Zarazne bolesti kao i moguÄe prijetnje vezane uz zarazne bolesti ne poznaju granice. Danas kad je prisutan intenzivan meÄunarodni promet ljudi i roba, oÄekivan je brži i jednostavniji prijenos i Å”irenje veÄ nam poznatih zaraznih bolesti, no takoÄer i pojava novih zaraznih bolesti. Time se postavljaju novi izazovi u spreÄavanju i suzbijanju zaraznih bolesti, Å”to je prepoznato od strane kako meÄunarodnih struÄnih i znanstvenih institucija, tako i od domaÄih.SpreÄavanje i suzbijanje zaraznih bolesti predstavlja javnozdravstveni prioritet u Europi (Direktiva Europskog parlamenta iz 1998. Godine, br. 2/19/98/EC), kako u zakonodavstvu Europske unije, tako i u dokumentima Europske regije Svjetske zdravstvene organizacije (WHO Grottaferatta 2000 Consensus Meeting on Surveillance of Infectious Diseases, Lyon 2002. Natural and intentional epidemic risks in Europe: Strengthening alert mechanism). Ovo je podruÄje prioritet i u zakonodavstvu Republike Hrvatske, a rad i organizacija Službe za epidemiologiju Hrvatskog zavoda za javno zdravstvo utvrÄeni su Zakonom o zdravstvenoj zaÅ”titi i Zakonom o zaÅ”titi puÄanstva od zaraznih bolesti te drugim zakonskim aktima. Služba za epidemiologiju sa Službom za mikrobiologiju Äini dio europske mreže epidemioloÅ”kog nadzora nad zaraznim bolestima
Health-related quality of life in elderly patients hospitalized with chronic heart failure
Background: Chronic heart failure is a very common condition in the elderly, characterized not only by high mortality rates, but also by a strong impact on health-related quality of life (HRQOL). Previous studies of HRQOL in elderly heart failure subjects have included mostly outpatients, and little is known about determinants of HRQOL in hospitalized elderly population, especially in Serbia. In this study, we tried to identify factors that influence HRQOL in elderly patients hospitalized with chronic heart failure in Serbia. Methods: The study population consisted of 136 patients aged 65 years or older hospitalized for chronic heart failure. HRQOL was assessed using the Minnesota Living with Heart Failure questionnaire. Predictors of HRQOL were identified by multiple linear regression analysis. Results: Univariate analysis showed that patients with lower income, a longer history of chronic heart failure, and longer length of hospital stay, as well as those receiving aldosterone antagonists and digoxin, taking multiple medications, in a higher NYHA class, and showing signs of depression and cognitive impairment had significantly worse HRQOL. Presence of depressive symptoms (P<0.001), higher NYHA class (P=0.021), lower income (P=0.029), and longer duration of heart failure (P=0.049) were independent predictors of poor HRQOL. Conclusion: Depressive symptoms, higher NYHA class, lower income, and longer duration of chronic heart failure are independent predictors of poor HRQOL in elderly patients hospitalized with chronic heart failure in Serbia. Further, there is an association between multiple medication usage and poor HRQOL, as well as a negative impact of cognitive impairment on HRQOL. Hence, measures should be implemented to identify such patients, especially those with depressive symptoms, and appropriate interventions undertaken in order to improve their HRQOL.publishedVersio